SCHEMBL103406

SCHEMBL103406

O=S(=O)(F)C(F)(F)C(F)(F)C(F)(F)S(=O)(=O)F

nearest known ligand 0.33

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.33
CA1 P00915 3/20 0.33
CA7 P43166 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
MMP1 P03956 2/20 0.32
MMP2 P08253 2/20 0.32
MMP9 P14780 2/20 0.32
MMP8 P22894 2/20 0.32
MMP13 P45452 2/20 0.32
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL867361 0.92 CA2 (0.39) CA2CA1CA7CA13MMP1
SCHEMBL13684270 0.89 CA2 (0.43) CA2CA1CA7CA13MMP1
SCHEMBL11788241 0.89 CA2 (0.43) CA2CA1CA7CA13MMP1
SCHEMBL156570 0.86 CA2 (0.42) CA2CA1CA7CA13MMP1
SCHEMBL2553998 0.85 TSHR (0.37) CA2CA1MMP1MMP2MMP9
SCHEMBL1469751 0.84 CA2 (0.38) CA2CA1CA7CA13TSHR
SCHEMBL73684 0.83 CA2 (0.52) CA2CA1MMP1MMP2MMP9
SCHEMBL9856619 0.83 CA1 (0.30) CA2CA1MMP1MMP2MMP9
SCHEMBL9856188 0.83 TSHR (0.35) CA2CA1MMP1MMP2MMP9
Potassium Ion SCHEMBL9856186 0.83 CA1 (0.30) CA2CA1MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118420565-A Preparation method and application of cycloperfluoro-sulfonyl imide salt compound 苏州威迈芯材半导体有限公司 2024-08-02 CN claimed
US-9861977-B2 Multi-acid polymers and methods of making the same NISSAN NORTH AMERICA, INC. (US) 2018-01-09 US claimed
US-20170274368-A1 MULTI-ACID POLYMERS AND METHODS OF MAKING THE SAME NISSAN MOTOR CO., LTD. (JP) 2017-09-28 US claimed
EP-4733293-A1 METHOD FOR PRODUCING ALKYL FLUORIDE COMPOUND, AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALKYL FLUORIDE COMPOUND Mitsubishi Materials Electronic Chemicals Co., Ltd. (JP) 2026-04-29 EP disclosed
US-12489130-B2 Fluoropolymer comprising pendent groups with ionic bis(sulfonyl)imide moiety and perfluoroether terminal group 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-12-02 US disclosed
CN-120590338-A Preparation method of cyclic perfluorinated sulfonamide salt 苏州亚科科技股份有限公司 2025-09-05 CN disclosed
WO-2025022805-A1 AMINO GROUP ELIMINATING AGENT, REACTION PRODUCT PRODUCTION METHOD, REACTION PRECURSOR, REACTION PRECURSOR PRODUCTION METHOD, AND METHOD FOR PRODUCING OPTICALLY ACTIVE REACTION PRODUCT 三菱マテリアル電子化成株式会社 2025-01-30 WO disclosed
WO-2024262208-A1 METHOD FOR PRODUCING ALKYL FLUORIDE COMPOUND, AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALKYL FLUORIDE COMPOUND 三菱マテリアル電子化成株式会社 2024-12-26 WO disclosed
CN-118420565-A Preparation method and application of cycloperfluoro-sulfonyl imide salt compound 苏州威迈芯材半导体有限公司 2024-08-02 CN disclosed
CN-118420565-A Preparation method and application of cycloperfluoro-sulfonyl imide salt compound 苏州威迈芯材半导体有限公司 2024-08-02 CN disclosed
US-12034193-B2 Fluorinated copolymer and compositions and articles including the same 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-07-09 US disclosed
US-6649703-B2 Crosslinking sulfonyl groups of sulfonated polymers at least some crosslinking bonds bear an ionic charge, by allowing reaction between two sulfonyl groups from adjacent polymer chains to form crosslinks; dimensional stability HYDRO-QUEBEC (CA) 2003-11-18 US disclosed
US-20020160272-A1 Process for producing a modified electrolyte and the modified electrolyte KABUSHIKI KAISHA TOYOTA CHUO (JP) 2002-10-31 US disclosed
US-20020091201-A1 Cross-linked sulphonated polymers and their preparation process MICHOT CHRISTOPHE (FR) 2002-07-11 US disclosed
US-20020002240-A1 Cross-linked sulphonated polymers and method for preparing same MICHOT CHRISTOPHE (FR) 2002-01-03 US disclosed
EP-0058466-B1 CYCLIC PERFLUOROALIPHATIC ACID ANHYDRIDES AND AMIDE DERIVATIVES THEREOF MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1985-12-18 EP disclosed
US-4423197-A Cyclic perfluoroaliphatic-disulfonic acid anhydrides and sulfonamide derivatives thereof MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1983-12-27 US disclosed
US-4386214-A Process for the preparation of cyclic perfluoroaliphaticdisulfonic acid anhydrides MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1983-05-31 US disclosed
EP-0058466-A2 Cyclic perfluoroaliphatic acid anhydrides and amide derivatives thereof MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1982-08-25 EP disclosed
US-4329478-A Cyclic perfluoroaliphaticdisulfonic acid anhydrides MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1982-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170274368-A1 MULTI-ACID POLYMERS AND METHODS OF MAKING THE SAME FRS2, FXR2, PFAS CA2 595/4885CA1 2184/4885CA7 1049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.